(S)-5-(furo[3,2-c]pyridin-2-yl)-5-((6-methoxy-1-oxoisoindolin-2-yl)methyl)imidazolidine-2,4-dione

ID: ALA4092752

PubChem CID: 57561293

Max Phase: Preclinical

Molecular Formula: C20H16N4O5

Molecular Weight: 392.37

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cc4cnccc4o3)NC(=O)NC1=O)C2

Standard InChI:  InChI=1S/C20H16N4O5/c1-28-13-3-2-11-9-24(17(25)14(11)7-13)10-20(18(26)22-19(27)23-20)16-6-12-8-21-5-4-15(12)29-16/h2-8H,9-10H2,1H3,(H2,22,23,26,27)/t20-/m0/s1

Standard InChI Key:  QOWBVKQSFCSJAK-FQEVSTJZSA-N

Molfile:  

     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
    8.0151  -13.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6106  -14.6640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4276  -14.6594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5416  -15.4441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3588  -15.4441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9502  -14.1853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2915  -14.6674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8402  -15.3647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5171  -16.1107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6583  -15.4430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2005  -14.8316    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8329  -16.2413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1293  -16.6522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1343  -17.4652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8422  -17.8682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5465  -17.4523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5380  -16.6407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2583  -17.8537    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2666  -18.6709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8398  -16.1048    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5142  -14.4152    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8266  -13.8596    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6780  -13.2052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2820  -12.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9889  -13.0592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6903  -12.6491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6860  -11.8350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9744  -11.4327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2759  -11.8451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  3  2  1  0
  4  5  1  0
  5  2  1  0
  2  6  1  0
  6  7  1  0
  7  4  1  0
  3  8  1  0
  8  9  1  0
  9 13  1  0
 12 10  1  0
 10  8  1  0
 10 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 16 18  1  0
 18 19  1  0
  5 20  2  0
  7 21  2  0
  1 22  1  0
 22 25  1  0
 24 23  1  0
 23  1  2  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4092752

   (5S)-5-furo[3,2-c]pyridin-2-yl-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 392.37

Molecular Weight (Monoisotopic): 392.1121

AlogP: 1.53

#Rotatable Bonds: 4

Polar Surface Area: 113.77

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.49

CX Basic pKa: 3.86

CX LogP: 0.12

CX LogD: 0.08

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.65

Np Likeness Score: -0.23

References

1. Tong L, Kim SH, Rosner K, Yu W, Shankar BB, Chen L, Li D, Dai C, Girijavallabhan V, Popovici-Muller J, Yang L, Zhou G, Kosinski A, Siddiqui MA, Shih NY, Guo Z, Orth P, Chen S, Lundell D, Niu X, Umland S, Kozlowski JA..  (2017)  Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors.,  27  (14): [PMID:28558971] [10.1016/j.bmcl.2017.05.062]

Source

Source(1):

• Scientific Literature